Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Gensciences
company
About
Gensciences develops drugs that focus on underserved illnesses like hemophilia, metabolic diseases, and anti-tumor fields.
- 251 - 500
Highlights
Details
- Last Funding Type
- Series A
- Industries
- Biotechnology,Clinical Trials,Health Care,Pharmaceutical,Product Research
- Founded date
- Jan 1, 2019
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
—
Gensciences has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Mar 4, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 4, 2021 | Series A | — | 1 | — | — | Detail |
| Mar 4, 2021 | Series B | — | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Gensciences is funded by 2 investors.
Haitong Kaiyuan Investment
and Hygeia Capital LLC
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series B |
Hygeia Capital LLC
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
